Clinical trialNCT06974786RecruitingPhase 2Interventional

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

SponsorSCRI Development Innovations, LLCEnrollment100Multiple Myeloma (MM)Multiple Myeloma, Newly Diagnosed

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Henning Schade, MD
Colorado Blood Cancer Institute
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Gayathri Ravi, MD
Recruiting
Colorado Blood Cancer Institute
Denver, Colorado, United States
Henning Schade, MD
Recruiting
University of Iowa
Iowa City, Iowa, United States
Christopher Strouse, MD
Recruiting
University of North Carolina
Chapel Hill, North Carolina, United States
Samuel Rubinstein, MD
Recruiting
Oncology Hematology Care
Cincinnati, Ohio, United States
Withdrawn
the Ohio State University- the James Cancer Hospital and Solove Research Institute
Columbus, Ohio, United States
Naresh Bumma, MD
Recruiting
Scri Oncology Partners
Nashville, Tennessee, United States
Hans Lee, MD
Recruiting
University of Texas Southwestern
Dallas, Texas, United States
Aimaz Afrough, MD
Recruiting
Virginia Oncology Associates
Norfolk, Virginia, United States
Scott Cross, MD
Recruiting
University of Wisconsin Clinical Science Center
Madison, Wisconsin, United States
Timothy Schmidt, MD
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Ravi Narra, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Aug 2025
Primary completion: 30 Nov 2032
Completion: 30 Apr 2033
Last update posted: 4 Jun 2026
Registered enrollment: 100
Registry id: NCT06974786

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.